Lipopolysaccharide from Escherichia coli prevents indomethacin-induced gastric damage in rats: role of non-protein sulfhydryl groups and leukocyte adherence

Inflamm Res. 2009 Oct;58(10):717-23. doi: 10.1007/s00011-009-0040-8. Epub 2009 Apr 29.

Abstract

Objective and design: To investigate the role of non-protein sulfhydryl groups (NP-SH) and leukocyte adhesion in the protective effect of lipopolysaccharide (LPS) from Escherichia coli against indomethacin-induced gastropathy.

Materials or subjects: Male Wistar rats were divided into four groups: saline, LPS, saline + indomethacin and LPS + indomethacin, with six rats in each group.

Treatment: Rats were pretreated with LPS (300 microg/kg, by intravenous) or saline. After 6 h, indomethacin was administered (20 mg/kg, by gavage).

Methods: Three hours after treatments, rats were killed. Macroscopic gastric damage, gastric NP-SH concentration, myeloperoxidase (MPO) activity and mesenteric leukocyte adhesion (intravital microscopy) were assessed. Statistical analysis was performed using one-way analysis of variance followed by the Newman-Keuls test. Statistical significance was set at P < 0.05.

Results: LPS reduced the gastric damage, gastric MPO activity and increased gastric NP-SH concentration in indomethacin-induced gastropathy. LPS alone increased gastric NP-SH when compared to saline. Indomethacin increased leukocyte adhesion when compared to the saline, and LPS reduced indomethacin-induced leukocyte adhesion. In addition, LPS alone did not change leukocyte adhesion, when compared to the saline.

Conclusion: LPS protective effect against indomethacin-induced gastropathy is mediated by an increase in the NP-SH and a decrease in leukocyte-endothelial adhesion.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Adhesion / physiology
  • Disease Models, Animal
  • Endothelium / pathology
  • Endothelium / physiology
  • Escherichia coli* / metabolism
  • Gastric Mucosa / metabolism
  • Indomethacin / adverse effects
  • Leukocytes / pathology*
  • Leukocytes / physiology
  • Lipopolysaccharides / metabolism
  • Lipopolysaccharides / therapeutic use*
  • Male
  • Rats
  • Rats, Wistar
  • Stomach / pathology
  • Stomach Diseases / chemically induced
  • Stomach Diseases / metabolism*
  • Stomach Diseases / prevention & control*
  • Sulfhydryl Compounds / metabolism*

Substances

  • Lipopolysaccharides
  • Sulfhydryl Compounds
  • Indomethacin